Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonsquamous Non-small Cell Lung Cancer”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)UnknownNCT02631460
What this trial is testing

S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC

Who this might be right for
NSCLC
Sun Yat-sen University 470
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Testing effectiveness (Phase 2)Study completedNCT01126736
What this trial is testing

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eisai Inc. 98
Not applicableStudy completedNCT02420405
What this trial is testing

Mutation Detection of EBUS-TBNA Specimens Using NGS

Who this might be right for
Lung Cancer
Jiayuan Sun 78
Large-scale testing (Phase 3)Looking for participantsNCT05973773
What this trial is testing

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

Who this might be right for
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc. 272
Large-scale testing (Phase 3)Study completedNCT00762034
What this trial is testing

Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 939
Large-scale testing (Phase 3)Study completedNCT00806819
What this trial is testing

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 718
Large-scale testing (Phase 3)UnknownNCT01481259
What this trial is testing

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 120
Not applicableStudy completedNCT02679443
What this trial is testing

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

Who this might be right for
Lung AdenocarcinomaNeutropeniaAnemia+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 161
Early research (Phase 1)Study completedNCT03380871
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNonsquamous Nonsmall Cell Neoplasm of Lung
BioNTech US Inc. 38
Large-scale testing (Phase 3)Study completedNCT00948675
What this trial is testing

Study of Participants With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Eli Lilly and Company 361
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04154956
What this trial is testing

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sanofi 389
Testing effectiveness (Phase 2)Looking for participantsNCT06246110
What this trial is testing

EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Who this might be right for
NSCLC
Eikon Therapeutics 70
Testing effectiveness (Phase 2)Ended earlyNCT02019979
What this trial is testing

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVNon-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Beth Israel Medical Center 14
Large-scale testing (Phase 3)UnknownNCT04416035
What this trial is testing

Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Zhejiang Teruisi Pharmaceutical Inc. 608
Testing effectiveness (Phase 2)Ended earlyNCT04265534
What this trial is testing

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 40
Early research (Phase 1)Study completedNCT02639091
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Who this might be right for
Medical Oncology
Bayer 36
Large-scale testing (Phase 3)UnknownNCT04750083
What this trial is testing

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Taizhou Hanzhong biomedical co. LTD 700
Load More Results